These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 1709506
1. Neurochemical consequences following injection of the substance P analogue, DiMe-C7, into the rat ventral tegmental area. Barnes JM, Barnes NM, Costall B, Cox AJ, Domeney AM, Kelly ME, Naylor RJ. Pharmacol Biochem Behav; 1990 Dec; 37(4):839-41. PubMed ID: 1709506 [Abstract] [Full Text] [Related]
2. Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat. Hagan RM, Jones BJ, Jordan CC, Tyers MB. Br J Pharmacol; 1990 Feb; 99(2):227-32. PubMed ID: 1691672 [Abstract] [Full Text] [Related]
3. The behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area or substantia nigra of rat brain. Eison AS, Eison MS, Iversen SD. Brain Res; 1982 Apr 22; 238(1):137-52. PubMed ID: 6177380 [Abstract] [Full Text] [Related]
11. Behavioural effects of tachykinins and related peptides. Elliott PJ, Iversen SD. Brain Res; 1986 Aug 27; 381(1):68-76. PubMed ID: 2428433 [Abstract] [Full Text] [Related]
12. Intra-median raphe infusions of muscimol and the substance P analogue DiMe-C7 produce hyperactivity: role of serotonin neurons. Paris JM, Lorens SA. Behav Brain Res; 1987 Aug 27; 26(2-3):139-51. PubMed ID: 2447909 [Abstract] [Full Text] [Related]
13. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Kalivas PW, Burgess SK, Nemeroff CB, Prange AJ. Neuroscience; 1983 Mar 27; 8(3):495-505. PubMed ID: 6406930 [Abstract] [Full Text] [Related]
14. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine. Altier N, Stewart J. J Pharmacol Exp Ther; 1998 Apr 27; 285(1):208-15. PubMed ID: 9536012 [Abstract] [Full Text] [Related]
15. Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain. Hagan RM, Butler A, Hill JM, Jordan CC, Ireland SJ, Tyers MB. Eur J Pharmacol; 1987 Jun 19; 138(2):303-5. PubMed ID: 2442006 [No Abstract] [Full Text] [Related]
16. A functional interaction between the mesolimbic dopamine system and vasopressin release in the regulation of blood pressure in conscious rats. Cornish JL, Wilks DP, Van den Buuse M. Neuroscience; 1997 Nov 19; 81(1):69-78. PubMed ID: 9300402 [Abstract] [Full Text] [Related]
17. The C-terminal fragment of substance P enhances dopamine release in nucleus accumbens but not in neostriatum in freely moving rats. Boix F, Huston JP, Schwarting RK. Brain Res; 1992 Oct 02; 592(1-2):181-6. PubMed ID: 1280516 [Abstract] [Full Text] [Related]
18. Inhibition of cardiac baroreflex sensitivity after central dopaminergic stimulation. van den Buuse M, Wilks DP, Cornish JL. Clin Exp Pharmacol Physiol; 1998 Oct 02; 25(7-8):624-6. PubMed ID: 9673440 [Abstract] [Full Text] [Related]
19. Intra-raphe neurokinin-induced hyperactivity: effects of 5,7-dihydroxytryptamine lesions. Paris JM, Mitsushio H, Lorens SA. Brain Res; 1989 Jan 02; 476(1):183-8. PubMed ID: 2464417 [Abstract] [Full Text] [Related]
20. Evidence for dose-dependent positively and negatively reinforcing effects of the substance P C-terminal analog DIME-C7. Hasenöhrl RU, Gerhardt P, Huston JP. Neuropeptides; 1990 Dec 02; 17(4):205-11. PubMed ID: 1709480 [Abstract] [Full Text] [Related] Page: [Next] [New Search]